Turalio 125MG, 120CT
Ended Awarded Last action
- Contract number
- 15B50526F00000107
- Awardee
-
Daiichi Sankyo, Inc. UEI YUKQY5G72Q29
- Awarding agency
-
Federal Medical Center Carswell
Correctional Facilities, Department of Justice
- Obligated
- $22,725
Award facts
- Contract value 100% obligated
- $22,725.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Basking Ridge, Bernards, NJ, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $22.7K, awards Daiichi Sankyo, Inc. a supply contract for TURALIO (pexidartinib) 125mg in 120-count bottles to support the Federal Medical Center Carswell, a civilian medical facility within the Department of Veterans Affairs system. The award is structured as a firm fixed-price delivery order with no set-aside designation, issued under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). Performance will be completed by March 31, 2026, with the award date of March 1, 2026. Daiichi Sankyo, a for-profit pharmaceutical manufacturer headquartered in Basking Ridge, New Jersey, serves as the prime contractor with no documented subcontractors on this award.
This delivery order is issued against a larger Blanket Purchase Agreement established between Daiichi Sankyo and the VA National Acquisition Center on May 22, 2025, valued at approximately $80.2K and effective through May 2026 with optional renewal periods. The BPA authorizes VA healthcare facilities within Veterans Integrated Service Networks 20 and 22 to procure TURALIO on an as-needed basis without additional competitive solicitations. TURALIO is a specialized medication indicated for treating tenosynovial giant cell tumor, a rare musculoskeletal condition affecting veteran populations. The BPA structure incorporates firm fixed-price pricing with Public Law 2026 pricing updates, enabling streamlined pharmaceutical procurement while maintaining budgetary control across participating VA medical centers.
Quick answers
Who was awarded contract 15B50526F00000107?
15B50526F00000107 was awarded to Daiichi Sankyo, Inc. by Federal Medical Center Carswell (Correctional Facilities) on March 1, 2026.
How much is contract 15B50526F00000107 worth?
The government has obligated $22,725 on 15B50526F00000107.
Is contract 15B50526F00000107 an order under another contract?
Yes. 15B50526F00000107 is a delivery order under 36F79718D0403, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B50526F00000107 competed?
The extent of competition for 15B50526F00000107 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award